Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β2-Agonist-Only Treatment
- PMID: 35202561
- PMCID: PMC9838630
- DOI: 10.1164/rccm.202112-2788LE
Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β2-Agonist-Only Treatment
Comment on
-
Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β2-Agonist-Only Treatment.Am J Respir Crit Care Med. 2022 Apr 15;205(8):971-972. doi: 10.1164/rccm.202111-2465LE. Am J Respir Crit Care Med. 2022. PMID: 35202554 Free PMC article. No abstract available.
References
-
- Reddel HK, FitzGerald JM, Bateman ED, Bacharier LB, Becker A, Brusselle G, et al. GINA 2019: a fundamental change in asthma management. Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. Eur Respir J . 2019;53:1901046. - PubMed
-
- Kaiser SV, Huynh T, Bacharier LB, Rosenthal JL, Bakel LA, Parkin PC, et al. Preventing exacerbations in preschoolers with recurrent wheeze: a meta-analysis. Pediatrics . 2016;137:e20154496. - PubMed